These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2438532)

  • 1. In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imaging.
    Kjaer L; Thomsen C; Iversen P; Henriksen O
    Magn Reson Imaging; 1987; 5(1):23-30. PubMed ID: 2438532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prostate by magnetic resonance imaging.
    Larkin BT; Berquist TH; Utz DC
    Magn Reson Imaging; 1986; 4(1):53-8. PubMed ID: 2419725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic resonance imaging in the diagnosis of prostatic carcinoma and benign hyperplasia].
    Fujiwara K; Isaka S; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1336-42. PubMed ID: 2480470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.
    Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL
    Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report.
    Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA
    J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using endorectal 1H magnetic resonance spectroscopy].
    Saikawa S; Suzuki Y; Tomoi M; Yoshida M; Ishii Y; Okada K
    Nihon Hinyokika Gakkai Zasshi; 1995 Nov; 86(11):1673-80. PubMed ID: 8551711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue characterization of intracranial tumors by MR imaging. In vivo evaluation of T1- and T2-relaxation behavior at 1.5 T.
    Kjaer L; Thomsen C; Gjerris F; Mosdal B; Henriksen O
    Acta Radiol; 1991 Nov; 32(6):498-504. PubMed ID: 1742132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of the prostate.
    Bryan PJ; Butler HE; Nelson AD; LiPuma JP; Kopiwoda SY; Resnick MI; Cohen AM; Haaga JR
    AJR Am J Roentgenol; 1986 Mar; 146(3):543-8. PubMed ID: 2418665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of the prostate.
    Poon PY; McCallum RW; Henkelman MM; Bronskill MJ; Sutcliffe SB; Jewett MA; Rider WD; Bruce AW
    Radiology; 1985 Jan; 154(1):143-9. PubMed ID: 2578070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI.
    Liney GP; Turnbull LW; Lowry M; Turnbull LS; Knowles AJ; Horsman A
    Magn Reson Imaging; 1997; 15(10):1177-86. PubMed ID: 9408138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE; Hutchinson CE; Buckley DL
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of T1 measurements at 1.7 and 3.4 MHz in the diagnosis of prostatic carcinoma.
    Smith FW; Cherryman GR; Steyn JH
    Magn Reson Med; 1985 Aug; 2(4):350-4. PubMed ID: 2419731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results.
    de Bazelaire CM; Duhamel GD; Rofsky NM; Alsop DC
    Radiology; 2004 Mar; 230(3):652-9. PubMed ID: 14990831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.
    Kahn T; Bürrig K; Schmitz-Dräger B; Lewin JS; Fürst G; Mödder U
    Radiology; 1989 Dec; 173(3):847-51. PubMed ID: 2479050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MRI of the prostate. Calculated imaging. Preliminary experience: 28 cases].
    Gevenois PA; Van Regemorter G; Ghysels M; Delepaut A; Van Gansbeke D; Struyven J
    J Radiol; 1988 Apr; 69(4):275-9. PubMed ID: 2455044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
    Ren J; Huan Y; Wang H; Chang YJ; Zhao HT; Ge YL; Liu Y; Yang Y
    Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings.
    Schiebler ML; Tomaszewski JE; Bezzi M; Pollack HM; Kressel HY; Cohen EK; Altman HG; Gefter WB; Wein AJ; Axel L
    Radiology; 1989 Jul; 172(1):131-7. PubMed ID: 2472644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulative interstitial laser-induced thermotherapy of benign prostatic hyperplasia: online imaging with a T2-weighted fast spin-echo MR sequence--experience in six patients.
    Mueller-Lisse UG; Thoma M; Faber S; Heuck AF; Muschter R; Schneede P; Weninger E; Hofstetter AG; Reiser MF
    Radiology; 1999 Feb; 210(2):373-9. PubMed ID: 10207417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
    Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
    Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR spectroscopy of the prostate at 3T: measurements of relaxation times and quantification of prostate metabolites using water as an internal reference.
    Weis J; Ortiz-Nieto F; Ahlström H
    Magn Reson Med Sci; 2013 Dec; 12(4):289-96. PubMed ID: 24172792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.